Tagged as: Simils Bio

Similis Bio and Blau Farmaceutica Enter into Development and License Agreement for Biosimilars

On October 25, 2022, JSR Life Sciences and Blau Farmaceutica announced that Similis Bio, JSR Life Sciences’s business unit focused on biosimilar development, has signed its first development and license agreement with Blau Farmaceutica, a Brazilian pharmaceutical company. According to the press release, the agreement contemplates a multi-product and multi-year…

Read More